Drugs / TGFβR-KO CAR-EGFR T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04976218 | Mar 2022 → Dec 2023 | cancer | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TGFβR-KO CAR-EGFR T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04976218 ↗ |
| Target | EGFR | “CAR-EGFR-TGFβR-KO T cell” NCT04976218 ↗ |